Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Cytokines in chronic respiratory diseases.

Atamas SP, Chapoval SP, Keegan AD.

F1000 Biol Rep. 2013;5:3. doi: 10.3410/B5-3. Epub 2013 Feb 1.

2.

Viral infection and aging as cofactors for the development of pulmonary fibrosis.

Naik PK, Moore BB.

Expert Rev Respir Med. 2010 Dec;4(6):759-71. doi: 10.1586/ers.10.73. Review.

3.

Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance.

Kikuchi N, Ishii Y, Morishima Y, Yageta Y, Haraguchi N, Itoh K, Yamamoto M, Hizawa N.

Respir Res. 2010 Mar 18;11:31. doi: 10.1186/1465-9921-11-31.

4.

Overexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis.

Kimura T, Ishii Y, Yoh K, Morishima Y, Iizuka T, Kiwamoto T, Matsuno Y, Homma S, Nomura A, Sakamoto T, Takahashi S, Sekizawa K.

Am J Pathol. 2006 Jul;169(1):96-104.

5.

Interleukin-12 is not essential for silicosis in mice.

Davis GS, Pfeiffer LM, Hemenway DR, Rincon M.

Part Fibre Toxicol. 2006 Jan 5;3:2.

6.

Helper T cells and atherosclerosis: the cytokine web.

Baidya SG, Zeng QT.

Postgrad Med J. 2005 Dec;81(962):746-52. Review.

7.
8.

Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma.

Kim JH, Kim HY, Kim S, Chung JH, Park WS, Chung DH.

Am J Pathol. 2005 Nov;167(5):1231-41.

9.

The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis.

Barbarin V, Nihoul A, Misson P, Arras M, Delos M, Leclercq I, Lison D, Huaux F.

Respir Res. 2005 Oct 7;6:112.

10.
11.

Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study.

Suárez-Méndez R, García-García I, Fernández-Olivera N, Valdés-Quintana M, Milanés-Virelles MT, Carbonell D, Machado-Molina D, Valenzuela-Silva CM, López-Saura PA.

BMC Infect Dis. 2004 Oct 22;4:44.

12.

Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia.

Jakubzick C, Choi ES, Carpenter KJ, Kunkel SL, Evanoff H, Martinez FJ, Flaherty KR, Toews GB, Colby TV, Travis WD, Joshi BH, Puri RK, Hogaboam CM.

Am J Pathol. 2004 Jun;164(6):1989-2001.

13.

Prolonged allergen challenge in mice leads to persistent airway remodelling.

McMillan SJ, Lloyd CM.

Clin Exp Allergy. 2004 Mar;34(3):497-507.

14.

Interleukin-4 and 13 concentrations in infants at risk to develop Bronchopulmonary Dysplasia.

Baier RJ, Loggins J, Kruger TE.

BMC Pediatr. 2003 Aug 18;3:8. Epub 2003 Aug 18.

15.

Impact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblasts.

Jakubzick C, Choi ES, Kunkel SL, Joshi BH, Puri RK, Hogaboam CM.

Am J Pathol. 2003 May;162(5):1475-86.

16.
17.

Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture--primary culture cells markedly differ from fourth-passage cells.

Zimmermann T, Kunisch E, Pfeiffer R, Hirth A, Stahl HD, Sack U, Laube A, Liesaus E, Roth A, Palombo-Kinne E, Emmrich F, Kinne RW.

Arthritis Res. 2001;3(1):72-6. Epub 2000 Nov 21.

18.

Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice.

Whitman SC, Ravisankar P, Elam H, Daugherty A.

Am J Pathol. 2000 Dec;157(6):1819-24.

19.
20.

Interleukin 4 in systemic sclerosis: not just an increase.

Atamas SP, White B.

Clin Diagn Lab Immunol. 1999 Sep;6(5):658-9. Review. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk